通过多方面的实验策略,提高大肠杆菌中的指标产量
Jianianhua Luo1, Jiahui Xu1, Qi Li2
1Jiangsu Co-Innovation Center of Efficient Processing and Utilization of Forest Resources, Nanjing Forestry University, Nanjing 210037, China; College of Chemical Engineering, Nanjing Forestry University, Nanjing 210037, China.
Bioorganic chemistry
|May 15, 2025
概括
这项研究介绍了一种新型的微生物生产的印第安,色染料的前体,从托芬在工程化大肠杆菌. 优化的共同种植系统实现了14倍的产量改善,使可持续的全年生产成为可能.
科学领域:
- 生物技术是生物技术.
- 合成生物学 合成生物学
- 代谢工程是代谢工程.
背景情况:
- 印地是一种有价值的植物原料,可用于印地和印地鲁,具有广泛的工业应用.
- 目前的植物性生产方法受到季节性和地理限制的限制.
- 开发一种可持续的,与植物无关的印加生产路线是非常可取的.
研究的目的:
- 建立一个强大的微生物系统,用于生物合成.
- 优化工程化的大肠杆菌宿主,以实现高产量的印加生产.
- 开发一个可扩展和可持续的过程,为全年的印加供应提供.
主要方法:
- 关键酶 (TnaA,MeFMO,PtUGT2突变体) 在大肠杆菌中的共同表达.
- 实施UDP-葡萄糖回收和NADPH再生系统.
- 设计和优化共同培养策略以减轻代谢负担.
主要成果:
- 获得了1043mg/L的最大指标产量,其摩尔转换率为48.1%.
- 与单株系统相比,印度的产量增加了14倍.
- 成功建立了一种植物独立的微生物合成途径,用于indican.
结论:
- 开发的多方面的微生物战略为印第安生产提供了一个高效和可持续的替代方案.
- 这种独立于植物的方法为持续,全年持续的印加供应铺平了道路.
- 工程化的大肠杆菌系统为工业印第安制造提供了一个可扩展的平台.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


